Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urban Novak

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|August 18, 2020
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)Alden Alberto Moccia, Sämi Schär, Stefanie Hayoz, et al.
Protein Science : a Publication of the Protein Society|January 6, 2023
Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg<sup>2</sup>Francesca Paoletti, Sonia Covaceuszach, Alberto Cassetta, et al.
Leukemia Research|December 16, 2016
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D Heini, Martin D Berger, Katja Seipel, et al.
Blood|January 10, 2016
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomasMélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, et al.
Cells|September 9, 2022
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell LymphomaAlexander D Heini, Ulrike Bacher, Naomi Porret, et al.
Annals of Hematology|December 25, 2016
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patientsStefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, et al.
Genes, Chromosomes & Cancer|November 23, 2019
Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemiaJohanna Flach, Evgenii Shumilov, Raphael Joncourt, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and CytopathologyEvgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, et al.
Oncology|September 14, 2022
Decision-Making among Experts in Advanced Hodgkin LymphomaFelicitas Hitz, Noémie Lang, Ulrich Mey, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|August 18, 2020
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)Alden Alberto Moccia, Sämi Schär, Stefanie Hayoz, et al.
Protein Science : a Publication of the Protein Society|January 6, 2023
Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg<sup>2</sup>Francesca Paoletti, Sonia Covaceuszach, Alberto Cassetta, et al.
Leukemia Research|December 16, 2016
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 yearsAlexander D Heini, Martin D Berger, Katja Seipel, et al.
Blood|January 10, 2016
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomasMélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, et al.
Cells|September 9, 2022
Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell LymphomaAlexander D Heini, Ulrike Bacher, Naomi Porret, et al.
Annals of Hematology|December 25, 2016
BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patientsStefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani, et al.
Genes, Chromosomes & Cancer|November 23, 2019
Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemiaJohanna Flach, Evgenii Shumilov, Raphael Joncourt, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and CytopathologyEvgenii Shumilov, Paolo Mazzeo, Martin S Zinkernagel, et al.
Oncology|September 14, 2022
Decision-Making among Experts in Advanced Hodgkin LymphomaFelicitas Hitz, Noémie Lang, Ulrich Mey, et al.
Leukemia & Lymphoma|August 19, 2021
A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomasMaria C Pirosa, Lu Zhang, Felicitas Hitz, et al.
Pageof 11